Isaac Guerrero-Hurtado

Malaga, AN 29071, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Plasma Concentrations of Endotoxin Lipopolysaccharide and High-Mobility Group Box 1 Protein Are Consistent Sex-Specific Biomarkers of Alcohol Abstinence Associated with Alcohol Use Disorder.

Plasma Concentrations of Endotoxin Lipopolysaccharide and High-Mobility Group Box 1 Protein Are Consistent Sex-Specific Biomarkers of Alcohol Abstinence Associated with Alcohol Use Disorder.

Journal: Toxics

Published: April 08, 2026

Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study.

Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study.

Journal: Toxics

Published: January 31, 2024

Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations.

Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations.

Journal: Frontiers in immunology

Published: June 19, 2023

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.

Journal: Frontiers in immunology

Published: September 16, 2021

Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.

Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.

Journal: Journal of clinical medicine

Published: May 11, 2020

Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation.

Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation.

Journal: Journal of clinical medicine

Published: March 05, 2020

The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.

The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.

Journal: Free radical biology & medicine

Published: February 12, 2019

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway.

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway.

Journal: Scientific reports

Published: August 08, 2017

Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.

Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.

Journal: Scientific reports

Published: April 04, 2017

Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß.

Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß.

Journal: PloS one

Published: October 06, 2016

Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.

Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 11, 2016

Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.

Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.

Journal: British journal of pharmacology

Published: July 29, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026